| ²é¿´: 343 | »Ø¸´: 2 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
Íõ¹ðÀ¼Òø³æ (СÓÐÃûÆø)
|
[½»Á÷]
ÇóÖúRiociguat Õâ¸öÐÂÒ©µÄÖÐÎÄÃû×Ö£¿Íò·Ö¸Ðл
|
||
|
ÏÂÃæÊÇÎÄÏ×Àï¶ÔËüµÄÃèÊö£¬Íò·Ö¸Ðл (BAY 63- 2521) is a first-in-class drug developed by Bayer Schering Pharma as an oral PH therapy. |
» ²ÂÄãϲ»¶
081700»¯Ñ§¹¤³ÌÓë¼¼Êõ Ò»Ö¾Ô¸Öк£Ñó 323 Çóµ÷¼ÁѧУ
ÒѾÓÐ12È˻ظ´
385·Ö ÉúÎïѧ£¨071000£©Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
²ÄÁÏר˶283Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
0703Çóµ÷¼Á383·Ö
ÒѾÓÐ5È˻ظ´
323Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
26¿¼Ñе÷¼Á0710 0860
ÒѾÓÐ8È˻ظ´
081700ѧ˶£¬323·Ö£¬Ò»Ö¾Ô¸Öйúº£Ñó´óѧÇóµ÷¼ÁѧУ
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ£¬³õÊԳɼ¨350Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸0817»¯Ñ§¹¤³ÌÓë¼¼Êõ£¬Çóµ÷¼Á
ÒѾÓÐ22È˻ظ´
085600£¬×¨Òµ¿Î»¯¹¤ÔÀí£¬321·ÖÇóµ÷¼Á
ÒѾÓÐ10È˻ظ´
hy52x
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 5363.3
- É¢½ð: 34
- ºì»¨: 1
- Ìû×Ó: 309
- ÔÚÏß: 417Сʱ
- ³æºÅ: 894154
- ×¢²á: 2009-11-05
- ÐÔ±ð: GG
- רҵ: ¸ß·Ö×Ӻϳɻ¯Ñ§
¡ï ¡ï ¡ï ¡ï
Íõ¹ðÀ¼(½ð±Ò+4,VIP+0):лл£¬ÐÁ¿àÁË 11-10 20:48
Íõ¹ðÀ¼(½ð±Ò+4,VIP+0):лл£¬ÐÁ¿àÁË 11-10 20:48
|
(BAY 63-2521)ÊÇÓÉBayer Schering Pharma Ëù·¢Õ¹µÄµÚÒ»Àà¿ÚÇ»pHÖÎÁÆÒ©Îï (BAY 63-2521)Õâ¾ÍÊǰݶú¹«Ë¾µÄÒ»¸öÒ©Ãû£¬Ã»±ØÒª·Òë°É [ Last edited by hy52x on 2009-11-9 at 20:39 ] |
2Â¥2009-11-09 20:35:22
sugar-tang
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 96.6
- É¢½ð: 1076
- ºì»¨: 1
- Ìû×Ó: 284
- ÔÚÏß: 80.9Сʱ
- ³æºÅ: 843493
- ×¢²á: 2009-09-08
- רҵ: ÉúÀíÉú̬ѧ
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
Íõ¹ðÀ¼(½ð±Ò+6,VIP+0):ÐÁ¿àÁË£¬ºÜÓÐÓã¬Ð»Ð» 11-10 20:49
Íõ¹ðÀ¼(½ð±Ò+6,VIP+0):ÐÁ¿àÁË£¬ºÜÓÐÓã¬Ð»Ð» 11-10 20:49
|
ά»ùÉϲ鵽µÄ£¬Riociguat (BAY 63-2521) is an experimental drug for the treatment of pulmonary arterial hypertension. As of March 2009, it is undergoing Phase III clinical trials. RiociguatÊÇÒ»ÖÖʵÑéÐÔÒ©ÎÓÃÓÚÖÎÁƷζ¯Âö¸ßѪѹ¡£½«ÓÚ2009Äê3Ô½øÐÐÁÙ´²ÊÔÑé¡£ÎÒ¾õµÃÕâÖÖÒ©¼ÈÈ»»¹Ö»ÊÇÔÚÁÙ´²ÊÔÑé½×¶Î¾Í²»»áÓÐÖÐÎÄÃûÄØ£¡ Ï£ÍûÒÔÉÏ×ÊÁ϶ÔÄãÓаïÖú ![]() [ Last edited by sugar-tang on 2009-11-9 at 20:48 ] |

3Â¥2009-11-09 20:46:40














»Ø¸´´ËÂ¥

10